Sorin Group: CarboMedics Sues ATS Medical for Breach of Contract
CarboMedics, Inc., a company fully-owned by Sorin (MIL:SRN),
announces today that it has filed suit against Minneapolis-based ATS
Medical, Inc. (NASDAQ: ATSI). The suit alleges that ATS failed to
order valve components as required by a long-term supply agreement.
The suit, which seeks enforcement of the supply agreement on a
continuing basis in addition to monetary damages, was filed in the
United States District Court for the District of Minnesota.
In 1990, CarboMedics gave ATS Medical a license to intellectual
property for a bileaflet heart valve designed by CarboMedics.
CarboMedics also agreed to develop the manufacturing processes by
which ATS Medical could bring that heart valve to market. In exchange,
ATS Medical entered into a long-term supply agreement with CarboMedics
whereby ATS Medical is required to purchase approximately $20 million
worth of valve components from CarboMedics between 2007 and 2011.
"We have completed a comprehensive review of the commercial
agreements at stake and as a result, feel we have to take this action
in order to seek enforcement of the contract," said Charles Griffin,
President, CarboMedics, Inc. "We are confident that in this case the
court will recognize the serious breach of basic contract rights by
ATS."
The Complaint is publicly available at the Public Access to Court
Electronic Records website: http://www.pacer.uscourts.gov (Civil
Docket Case No.: 0:06-cv-04601 (PAM/JSM)).
About the Sorin Group
The Sorin Group (Bloomberg: SRN.IM; Reuters: SORN.MI), a world
leader in the development of medical technologies for cardiac surgery,
offers innovative therapies for cardiac rhythm dysfunctions,
interventional cardiology and the treatment of chronic kidney
diseases. The Sorin Group includes: Dideco, CarboMedics, Inc., COBE
Cardiovascular, Inc., Stockert, Mitroflow, ELA Medical, Inc., Sorin
Biomedica, Bellco and Soludia. It has more than 4,500 employees
working at facilities in more than 80 countries throughout the world
to serve over 5,000 public and private treatment centers.
For more information: www.sorin.com